|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiac glycosides potently inhibit C-reactive protein synthesis in human hepatocytes 显示文摘 | KOLKHOF P GEERTS A SCHAFER S | 2010 | Biochem Biophys Res Commun2010，394，： | 1 |
| 2 | Finerenone, a novel selective non-steroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury显示文摘 | Kolkhof P Delbeck M Kretschmer A | 2014 | J Cardiovasc Pharmaeol2014，64，1： | 1 |
| 3 | Differentiation of argi-nine vasopressin antagonistic effects by selective V2 versus dual V2/Via receptor blockade in a preclinical heart failure model显示文摘 | Mondritzki T Kolkhof P Sabbah HN | 2011 | Am JTher2011，18，1： | 1 |
| 4 | Overexpression of PH-4,a novel putative proline 4-hydroxylase,modulates activity of hypoxia-inducible transcription factors显示文摘 | Oehme F Ellinghaus P Kolkhof P | 2002 | Biochem Biophys Res Commun2002，296，： | 1 |
| 5 | Molecular pharmacology of the mi-neralocorticoid receptor:Prospects for novel therapeutics显示文摘 | Kolkhof P Borden SA | 2012 | Mol Cell Endocrinol2012，350，2： | 1 |
| 6 | Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury 显示文摘 | Kolkhof P Delbeck M Kretschmer A | 2014 | J Cardiovasc Pharmacol2014，64，1： | 1 |
| 7 | Finerenone,a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury显示文摘 | Kolkhof P Delbeck M Kretschmer A | 2014 | Cardiovasc Pharmacol2014，64，1： | 1 |
| 8 | Improved survival and nephroprotection in hypertensive rats by BAY94-8862,a novel non-steroidal mineralocorticoid receptor antagonist显示文摘 | Kolkhof P Kretschmer A Baerfacker L | 2012 | Eur Heart2012，33，： | 1 |
| 9 | Overexpression of PH-4,a novel putative proline 4-hydroxylase,modulatesactivity of hypoxia-inducible transcription factors显示文摘 | Oehme F Ellinghaus P Kolkhof P | 2002 | Biochem Biophys Res Commun2002，296，2： | 1 |
| 10 | Nonsteroidal antago- nists of the mineralocorticoid receptor显示文摘 | KOLKHOF P NOWACK C EITNER F | 2015 | Curr Opin Nephrol Hy- pertens2015，24，5： | 1 |
| 11 | Differentiation of arginine vasopressin antagonistic effects by selective V2 ver sus dual V2/Vla receptor blockade in a preclinical heart fail- ure model显示文摘 | Mondritzki T Kolkhof P Sabbah HN | 2011 | Am J Ther2011，18，1： | 1 |
| 12 | Identification of 4H, 6H- benzoxepino oxazoles as novel squalene synthase inhibitors 显示文摘 | GRIEBENOW N BUCHMUELLER A KOLKHOF P | 2011 | Bioorg Med Chem Lett2011，21，12： | 1 |
| 13 | Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1显示文摘 | Amazit L Le Billan F Kolkhof P | 2015 | J Biol Chem2015，290，21： | 1 |
| 14 | Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/Vla receptor blockadein a preclinieal heart failure model显示文摘 | MONDRITZKI T KOLKHOF P SABBAH HN et ol | 2011 | Am J Ther2011，18，1： | 1 |
| 15 | Finerenone,a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury显示文摘 | Kolkhof P Delbeck M Kretschmer A | 2014 | J Cardiovasc Pharmacol2014，64，1： | 1 |
| 16 | Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors 显示文摘 | OEHME F ELL1NGHAUS P KOLKHOF P | 2002 | Biochem Biophys Res Commun2002，296，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员